Gee‐Chen Chang
National Chung Hsing University(TW)Chung Shan Medical University Hospital(TW)National Taiwan University Hospital(TW)Pulmonary Associates(US)University of Medicine 2 Yangon(MM)Institute of Biomedical Science(GB)Chung Shan Medical University(TW)National Taipei University(TW)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Peptidase Inhibition and Analysis
Most-Cited Works
- → Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study(2016)636 cited
- → Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer(2012)491 cited
- → Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling(2014)440 cited
- → Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC(2024)331 cited
- → Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial(2020)251 cited
- →